Navigation Links
Dyspepsia in Medical News

Two Studies at AACE 2009 Annual Meeting Highlight Effects of Welchol(R) (colesevelam HCl) on Blood Glucose and LDL-C in Patients with Type 2 Diabetes

... (n=1), abnormal liver function test (n=1) and dyspepsia (n=2). Events considered unlikely or unrelated ... of causality were constipation (11.0% vs. 7.0%), dyspepsia (8.3% vs. 3.5%), nausea (4.2% vs. 3.9%), ... (8.7% vs. 2.0%), nasopharyngitis (4.1% vs. 3.6%) dyspepsia (3.9% vs. 1.4%), hypoglycemia (3.0% vs. 2.3%), ...

Antacids Are Best First Choice for Indigestion

... 15 (HealthDay News) -- Starting treatment for dyspepsia -- the medical name for indigestion -- with ... new study says. "Most patients with new-onset dyspepsia are treated with empirical proton pump inhibitor ... But he added that, "overall, most patients with dyspepsia could and should be managed with antacids and H2 ...

ASGE offers guidelines on endoscopic treatment of dyspepsia

... Society for Gastrointestinal Endoscopy. dyspepsia may encompass a variety of more specific ... role of endoscopy in the evaluation of dyspepsia is both a pragmatic concern for the ... determinant in healthcare costs. "Since dyspepsia affects large numbers of people across a broad ...

New study examines brain-gut relationship in those suffering with stomach pain or discomfort

... brain-gut interaction in patients with functional dyspepsia and whether certain drugs can effectively relieve symptoms of this disorder. Functional dyspepsia is a costly and chronic disorder that can cause ... six medical centers in the U.S. The Functional dyspepsia Treatment Trial (FDTT) will determine if either ...

FDA Advisory Committee Recommendation on SEROQUEL XR Supplemental New Drug Applications

... 10%-13%), dry mouth (12%-37% vs. 1%-7%), constipation (6%-10% vs. 3%-6%), dyspepsia (5%-7% vs. 1%-4%), dizziness (10%-13% vs. 4%-11%), orthostatic hypotension ... (5% vs. 2%), nasal congestion (5% vs. 3%), SGPT increased (5% vs. 1%), and dyspepsia (5%-7% vs. 1%-4%). Please see Prescribing Information, including ...

FDA Advisory Committee Recommendation on SEROQUEL XR Supplemental New Drug Applications

... 10%-13%), dry mouth (12%-37% vs. 1%-7%), constipation (6%-10% vs. 3%-6%), dyspepsia (5%-7% vs. 1%-4%), dizziness (10%-13% vs. 4%-11%), orthostatic hypotension ... (5% vs. 2%), nasal congestion (5% vs. 3%), SGPT increased (5% vs. 1%), and dyspepsia (5%-7% vs. 1%-4%). Please see Prescribing Information, including ...

Chronic gastrointestinal symptoms in Korean population

... symptoms (n = 1153), subjects with GERD (n = 50), uninvestigated dyspepsia (n = 166) and IBS (n = 31) had significantly worse scores on most domains ... of life was significantly impaired in subjects with GERD, uninvestigated dyspepsia and IBS. It can be reasoned that a better understanding of the impact of ...

Chronic GI Troubles Keep Workers Off the Job

... with constipation (IBS-C), chronic constipation (CC) alone, or functional dyspepsia (FD) lost 10.3 hours of work per week, while those with gastroesophageal ... per week. Patients with IBS-C, chronic constipation and functional dyspepsia (chronic or recurrent pain or discomfort in the upper abdomen, including ...

Common abdominal pain may be due to a potentially treatable newly recognized inflammatory reaction

... examinations to 51 Swedish participants who complained of nonulcer dyspepsia as well as 49 randomly selected participants who had no pain. dyspepsia is chronic or recurrent pain, or a feeling of abdominal fullness after ...

New HIV Study Shows That Large Numbers of Women and People of Color Can Be Successfully Enrolled In U.S. HIV Clinical Studies

... arm were diarrhea (12%), nausea (7%), rash (6%), abdominal pain (5%), vomiting (4%), asthenia (3%), headache (2%), abdominal distension (2%), and dyspepsia (2%). This is not a complete list of all adverse drug reactions reported with the use of PREZISTA/r. Please see full Prescribing ...
Dyspepsia in Medical Technology

AstraZeneca Submits sNDAs for SEROQUEL XR(TM) for the Treatment of Bipolar Mania and Bipolar Depression

... vs 5%-7%), constipation (8%- 10% vs 3%-4%), SGPT increase (5% vs 1%), dyspepsia (5%-7% vs 1%-4%), lethargy (5% vs 2%), and weight gain (5% vs 1%). The ... for schizophrenia were dry mouth (12% vs 1%), constipation (6% vs 5%), dyspepsia (5% vs 2%), sedation (13% vs 7%), somnolence (12% vs 4%), dizziness (10% ...

SEROQUEL XR(TM) Receives Approval From FDA for Maintenance Treatment of Schizophrenia

... vs 5%-7%), constipation (8%- 10% vs 3%-4%), SGPT increase (5% vs 1%), dyspepsia (5%-7% vs 1%-4%), lethargy (5% vs 2%), and weight gain (5% vs 1%). The ... for schizophrenia were dry mouth (12% vs 1%), constipation (6% vs 5%), dyspepsia (5% vs 2%), sedation (13% vs 7%), somnolence (12% vs 4%), dizziness (10% ...

Study Results Present Efficacy and Safety Findings from the PHIRST-1 Study of Patients with Pulmonary Arterial Hypertension Taking Tadalafil Tablets Once Daily

... in the PHIRST-1 clinical trial were headache, myalgia, nasopharyngitis, flushing, respiratory tract infection, extremity pain, nausea, back pain, dyspepsia and nasal congestion. In rare instances, patients taking PDE5 inhibitors (including tadalafil) reported a sudden decrease or loss of vision or ...

Study Demonstrating Lurasidone Is Effective in Patients With Schizophrenia Published in The Journal of Clinical Psychiatry

... subjects) for lurasidone versus placebo were nausea (16% vs. 3%), headache (11.1% vs. 10%), constipation (11.1% vs. 5.6%), vomiting (11.1% vs. 5.6%), dyspepsia (11.1% vs. 3.3%), somnolence (11.1% vs. 3.3%), insomnia (10.0% vs. 3.3%) and sedation (10.0% vs. 4.4%). Lurasidone had a lower overall ...

FDA Approves ADCIRCA(TM) (Tadalafil) Tablets for the Treatment of Pulmonary Arterial Hypertension

... in the PHIRST-1 clinical trial were headache, myalgia, nasopharyngitis, flushing, respiratory tract infection, extremity pain, nausea, back pain, dyspepsia and nasal congestion. In rare instances, patients taking PDE5 inhibitors (including tadalafil) reported a sudden decrease or loss of vision or ...

Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF Presented at American Thoracic Society (ATS)

... 2 and 38% vs. 16% in CAPACITY 1), rash (31% vs. 10% and 34% vs. 13%), fatigue (28% vs. 21% and 33% vs. 20%), diarrhea (25% vs. 17% and 33% vs. 21%), dyspepsia (17% vs. 9% and 21% vs. 6%), and dizziness (19% vs. 10% and 18% vs. 10%). Rash was generally mild to moderate in both studies; only 2 patients (1 in ...

Study Reported Tadalafil Taken Once Daily Improved Erectile Function in Men with ED and Sexual Quality of Life in Couples

... with 5 points in the placebo group. Tadalafil 5 mg was generally well-tolerated, and the most frequently reported adverse events were headache, dyspepsia and nasal congestion. Three subjects in the tadalafil group discontinued their participation in the study due to adverse events. About Cialis ...

Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma

... (13% vs 4%), bronchitis (13% vs 8%), hypokalemia (13% vs 7%), hypertension (13% vs 7%), abdominal pain upper (12% vs 9%), hypotension (12% vs 3%), dyspepsia (11% vs 7%), nasopharyngitis (11% vs 8%), bone pain (11% vs 10%), arthralgia (11% vs 15%) and pruritus (10% vs 5%). About Millennium ...

Prolonged Progression-Free Survival Demonstrated by VELCADE(R) (Bortezomib) for Injection Based Induction Regimens in Transplant-Eligible Previously Untreated Multiple Myeloma Patients

... (13% vs 4%), bronchitis (13% vs 8%), hypokalemia (13% vs 7%), hypertension (13% vs 7%), abdominal pain upper (12% vs 9%), hypotension (12% vs 3%), dyspepsia (11% vs 7%), nasopharyngitis (11% vs 8%), bone pain (11% vs 10%), arthralgia (11% vs 15%) and pruritus (10% vs 5%). About Millennium ...

Long-term Follow Up Interim Data Show Nplate(TM) Increased and Sustained Platelet Counts in Adult Chronic ITP Patients

... (14 percent, 2 percent), Pain in Extremity (13 percent, 5 percent) , Abdominal Pain (11 percent, 0 percent), Shoulder Pain (8 percent, 0 percent), dyspepsia (7 percent, 0 percent), and Paresthesia (6 percent, 0 percent). -- As with all therapeutic proteins, patients may develop antibodies to the ...

More>>

Dyspepsia in Medical Definition

Pathology

... GERD - Achalasia - Esophageal cancer - Esophageal varices Stomach Peptic ulcer - Abdominal pain - Stomach cancer - Non-ulcer dyspepsia - Gastroparesis - Abdominal angina - Malabsorption (e.g. celiac disease , giardiasis ) - Pyloric stenosis Small intestine ...
Dyspepsia in Medical Dictionary

Acidosis

... Hernia ) Vomiting ( Emesis ) Indigestion ( dyspepsia ) dyspepsia (Poor Digestion ; Indigestion ) Nervous dyspepsia [Kellogg] ... Respiratory acidosis ...

Digestion

... In digestion Related Category: Pathology or dyspepsia , discomfort during or after eating caused by ... Dr Rob Hicks In digestion is also called dyspepsia and is a pain felt in the upper part of the ... for in digestion Antacids are taken to treat dyspepsia - better known as in digestion or heartburn ....

Dyspepsia

... dyspepsia Definition dyspepsia can be defined as painful, difficult, or ... , bloating , and stomach discomfort. dyspepsia - indigestion ; acid stomach ; upset ...

Heartburn

... Hernia ) Vomiting ( Emesis ) Indigestion ( dyspepsia ) dyspepsia (Poor Digestion ; Indigestion ) Nervous dyspepsia [Kellogg] ... heartburn Indigestion . A ...

Indigestion

... Indigestion Related Category: Pathology or dyspepsia , discomfort during or after eating caused by ... Dr Rob Hicks Indigestion is also called dyspepsia and is a pain felt in the upper part of the ... for indigestion Antacids are taken to treat dyspepsia - better known as indigestion or heartburn . ...

Dizziness

... Bone Marrow Transplant ation Breast Reconstruction Bronchoscopy ... Inflammation at injection sites, dysgeusia, fatigue , nausea , dyspepsia , fever , dizziness , and edema of the scrotum have been reported after treatment with the bovine (cow) cartilage product Catrix. ...

Fat

... a plantar callus . DUAL-ENERGY X-RAY ABSORPTIOMETRY (DEXA): A method of scanning the body to determine bone density and fat distribution. dyspepsia : Digestive upset, which can include nausea , vomiting , and heartburn . High cholesterol levels are linked to heart problems. This article ...

Food poisoning

... kitchen hygiene to avoid food poisoning Minimise intake of spicy foods , fatty foods , caffeine and alcohol, particularly if these give you dyspepsia Don't 'bolt' your food - instead, eat slowly and chew thoroughly Don't eat late at night ... An extremely dangerous form of food poisoning ...

Fructose

... (Hereditary Fructose Intolerance) FTT ( Failure to Thrive ) Functional Colitis (Irritable Bowel Syndrome (Functional Bowel )) Functional dyspepsia (Irritable Bowel Syndrome (Functional Bowel )) Functional Ovarian Cysts ( Ovarian Cysts ) ... Foods containing fructose - Fructose ...

Gastric ulcer

... ulcers . They occur when the membrane lining the digestive system breaks down or erodes. Statistics show an average of 20% of patients with dyspepsia have duodenal or gastric ulcer disease , 20% have irritable bowel syndrome , fewer than 1% of patients had cancer , and the range for ...

More>>

Dyspepsia in Biological Technology

AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Major Depressive Disorder

... vs 5%-7%), constipation (8%-10% vs 3%-4%), SGPT increase (5% vs 1%), dyspepsia (5%-7% vs 1%-4%), lethargy (5% vs 2%), and weight gain (5% vs 1%). The ... for schizophrenia were dry mouth (12% vs 1%), constipation (6% vs 5%), dyspepsia (5% vs 2%), sedation (13% vs 7%), somnolence (12% vs 4%), dizziness (10% ...

InterMune Reports Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF

... 2 and 38% vs. 16% in CAPACITY 1), rash (31% vs. 10% and 34% vs. 13%), fatigue (28% vs. 21% and 33% vs. 20%), diarrhea (25% vs. 17% and 33% vs. 21%), dyspepsia (17% vs. 9% and 21% vs. 6%), and dizziness (19% vs. 10% and 18% vs. 10%). Rash was generally mild to moderate in both studies; only 2 patients (1 in ...

FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania

... in clinical trials for schizophrenia and bipolar disorder somnolence (25-52% vs. 10-13%), dry mouth (12-37% vs. 1-7%), constipation (6-10% vs. 3-6%), dyspepsia (5-7% vs. 1-4%), dizziness (10-13% vs. 4-11%), orthostatic hypotension (7% vs. 5%), weight gain (7% vs. 1%), increased appetite (12% vs. 6%), fatigue ...
Other Contents
(Date:2/27/2015)... 27, 2015 Insight Accelerator Labs ... advance the development of an in-line urine flow ... is being developed in direct response to current ... accuracy and error margins with potentially grave consequences. ... measurement and provide trending data analysis to signal ...
(Date:2/27/2015)... Ford, Pennsylvania (PRWEB) February 27, 2015 ... the Spring Breast Augmentation Special at his Chadds Ford, ... 13 through May 1, 2015, and will be priced ... to the latest silicone implants, it will include more ... price and $250 worth of free Dysport. , Space ...
(Date:2/27/2015)... The Lymphoma Research Foundation (LRF) – the ... lymphoma research and serving the lymphoma community through a ... services – is continuing to make its presence known ... Miami area to host Swirl, A Wine Tasting Event ... on Thursday, March 26, 2015. This year’s wine selection ...
(Date:2/27/2015)... Over 440,000 patients die annually as a ... two jumbo jet airplanes crashing each day. Now more than ... an effort to do all they can to stay safe. ... the 17th U.S. Surgeon General, discusses the importance of safer ... to address safety issues to ensure that all our patients ...
(Date:2/27/2015)... Chicago, IL (PRWEB) February 27, 2015 ... Assistant Professor of Biomedical Engineering at Duke University, ... modification for boys and young men with Duchenne ... 18 in Nature Communications, and Gersbach will discuss ... be held March 11-14 in Washington, D.C. , ...
Breaking Medicine News(10 mins):Health News:Output Medical Joins Insight Accelerator Labs 2Health News:Output Medical Joins Insight Accelerator Labs 3Health News:Dr. Christopher Saunders Announces Spring Breast Augmentation Special at $3,950 2Health News:Dr. Christopher Saunders Announces Spring Breast Augmentation Special at $3,950 3Health News:Lymphoma Research Foundation Returns to Miami Beach For Exclusive Swirl Wine Tasting Event 2Health News:Dr. Richard Carmona, the 17th U.S. Surgeon General, and IntelliCentrics Raise Awareness in Mediaplanet’s “Patient Safety” Campaign 2Health News:Statement: New MDA-Funded Genetic Therapy Technique Targets DMD 2
(Date:1/22/2015)... , Jan. 13, 2015  Today, FreeWavz ( www.FreeWavz.com ... its crowdfunding campaign on Fundable, https://www.fundable.com/freewavz . ... of production capacity to meet customer demand. ... - http://photos.prnewswire.com/prnh/20150113/168790 Invented ...
(Date:1/22/2015)... 2015  BellBrook Labs, a leader in high throughput ... of a TR-FRET (time resolved Forster resonance energy ... a high throughput screening assay for glycosyltransferases and ... for sensitive detection of hundreds of human and ...
(Date:1/22/2015)... 20, 2015 NXT-ID, Inc. (NASDAQ: NXTD and NXTDW) ... on the recent success of the Wocket™ smart wallet at CES 2015 ... wallet was named as one of the "11 Hot Products at CES" ... Launched At CES So Far" by Newseveryday.com and "The top 10 gadgets ...
Breaking Biology News(10 mins):FreeWavz Launches on Fundable to Drive Speed-to-Market in 2015 2BellBrook Labs Launches a High Throughput Screening Assay for Glycosyltransferases with TR-FRET Readout 2CES Response for NXT-ID's Wocket Smart Wallet Kicks Off 2015 2CES Response for NXT-ID's Wocket Smart Wallet Kicks Off 2015 3
Other TagsOther Tags